Cargando…
Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
BACKGROUND: Platinum-based chemotherapy improves survival among patients with non-small cell lung cancer (NSCLC), but the efficiency is limited due to resistance. In this study, we aimed to identify the expression of Aurora-A and its correlation with cisplatin resistance and prognosis in NSCLC. METH...
Autores principales: | Xu, Jie, Yue, Cai-feng, Zhou, Wei-hua, Qian, Yuan-min, Zhang, Yan, Wang, Shao-wu, Liu, An-wen, Liu, Quentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237886/ https://www.ncbi.nlm.nih.gov/pubmed/25082261 http://dx.doi.org/10.1186/1479-5876-12-200 |
Ejemplares similares
-
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
por: Xu, Jie, et al.
Publicado: (2013) -
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013) -
Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis
por: Ma, Yuhua, et al.
Publicado: (2017) -
Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021) -
Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
por: Luo, Fan-Yan, et al.
Publicado: (2015)